BioLineRx (BLRX), Genentech Enter Research Collaboration to Investigate Combination of BL-8040 with Atezolizumab

September 7, 2016 7:03 AM

BioLineRx Ltd. (NASDAQ: BLRX) today announced that it has entered into a collaboration with Genentech, a member of the Roche ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found